Pharmacokinetic study of two different rifabutin doses co-administered with lopinavir/ritonavir in African HIV and tuberculosis co-infected adult patients

This study aimed to assess the pharmacokinetic profile of 150  mg rifabutin (RBT) taken every other day (every 48 h) versus 300 mg RBT taken every other day (E.O.D), both in combination with lopinavir/ritonavir...

Source: BMC Infectious Diseases - June 26, 2020 Category: Infectious Diseases Authors: Seni Kouanda, Henri Gautier Ouedraogo, Kadari Cisse, Tegwinde Rebeca Compaor é, Giorgia Sulis, Serge Diagbouga, Alberto Roggi, Grissoum Tarnagda, Paola Villani, Lassana Sangare, Jacques Simporé, Mario Regazzi and Alberto Matteelli Tags: Research article Source Type: research